Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Heska Corp (NASDAQ:HSKA)

97.79
Delayed Data
As of 4:00pm ET
 -0.80 / -0.81%
Today’s Change
46.51
Today|||52-Week Range
115.00
+36.58%
Year-to-Date
No recent news for Heska Corp.

Today’s Trading

Previous close98.59
Today’s open97.56
Day’s range96.53 - 98.02
Volume46,232
Average volume (3 months)80,310
Market cap$712.4M
Dividend yield0.42%
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+93.24%
Earnings growth (this year)+42.77%
Earnings growth (next 5 years)+16.70%
Revenue growth (last year)+24.37%
P/E ratio49.6
Price/Sales4.05
Price/Book7.96

Competitors

 Today’s
change
Today’s
% change
AKBAAkebia Therapeutics ...-0.03-0.20%
VNDAVanda Pharmaceutical...-0.15-0.93%
FLXNFlexion Therapeutics...+0.08+0.36%
RVNCRevance Therapeutics...-0.30-1.28%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)$0.41
Annual revenue (last year)$130.1M
Annual profit (last year)$10.5M
Net profit margin8.08%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Kevin S. Wilson
Secretary, Chief Operating &
Strategist Officer
Jason A. Napolitano
Corporate headquarters
Loveland, Colorado

Forecasts